Diabetes Labelling People Management 
Pharmaceutical Business Review
MARCH 11, 2024
This label expansion follows a supplemental New Drug Application (sNDA) submitted by the company. Participants in the trial, all of whom were aged 45 years or above with a body mass index (BMI) of 27 kg/m2 or higher and without a history of diabetes, were observed over a five-year period.
The Thyroid Pharmacist
NOVEMBER 15, 2024
There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.
Expert insights. Personalized for you.
59 
Let's personalize your content